Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-16
DOI
10.1038/s41467-020-19334-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis
- (2019) Amanda R. Kupstas et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
- (2019) Gabriele Campanella et al. NATURE MEDICINE
- Deep learning-based classification of mesothelioma improves prediction of patient outcome
- (2019) Pierre Courtiol et al. NATURE MEDICINE
- Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies
- (2018) Babak Ehteshami Bejnordi et al. MODERN PATHOLOGY
- Predicting cancer outcomes from histology and genomics using convolutional networks
- (2018) Pooya Mobadersany et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
- (2018) Nicolas Coudray et al. NATURE MEDICINE
- Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study
- (2017) Pu Cheng et al. Oncotarget
- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
- (2017) D. Craig Allred et al. Journal of the National Comprehensive Cancer Network
- Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update
- (2016) Ping Tang et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis
- (2016) Geert Litjens et al. Scientific Reports
- Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma
- (2015) Sonia Narendra et al. Annals of Diagnostic Pathology
- Limitations of tissue microarrays compared with whole tissue sections in survival analysis
- (2010) M. HAYSAM KHOUJA et al. Oncology Letters
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies
- (2009) Jaclyn A. Freudenberg et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact
- (2009) Ana-Cristina Vargas et al. Future Oncology
- Current issues in ER and HER2 testing by IHC in breast cancer
- (2008) Allen M Gown MODERN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started